ArticleDiagnostics (Basel, Switzerland)2026
Salivary CD5L as a Potential Non-Invasive Biomarker for Pathological Staging and Prognostic Assessment in Oral Squamous Cell Carcinoma.
Nan-Chin Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.